Italy

5 Vaccines Approved for Use in Italy

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
15 trials in 12 countries
Approval Source: ema.europa.eu
RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Approval Source: ema.europa.eu
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: ema.europa.eu

3 in Clinical Trials in Italy

Protein Subunit

Laboratorios Hipra SA

COVID-19 vaccine HIPRA

7 trials in 4 countries
Non Replicating Viral Vector

ReiThera

GRAd-COV2

5 trials in 12 countries
DNA

Takis

COVID-eVax

2 trials in 1 country